Segmentation, Major Trends, and Competitive Analysis of the Point of Care Diagnostics Market

The point of care diagnostics market is on track for substantial growth in the coming years, driven by technological advancements and changing healthcare delivery models. This sector is evolving rapidly as new testing platforms and digital innovations make diagnostics more accessible and efficient across various settings.

Projected Global Size and Growth of the Point of Care Diagnostics Market by 2030
The point of care diagnostics market is expected to reach a value of $81.23 billion by 2030, expanding at a compound annual growth rate (CAGR) of 9.6%. This growth is propelled by several factors including the continuous development of multiplex testing platforms, the increasing integration of digital connectivity within diagnostic tools, and the growing prominence of home healthcare diagnostics. Additionally, the rising demand for personalized medicine and the adoption of AI-driven diagnostic technologies are significant contributors. Key trends forecasted over this period include the widespread use of rapid diagnostic test kits, a surge in home-based testing devices, growing interest in infectious disease point of care tests, expansion of over-the-counter (OTC) diagnostic products, and a greater focus on real-time clinical decision support.

Download a free sample of the point of care diagnostics market report:
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Companies in the Point of Care Diagnostics Industry
Several prominent players dominate the point of care diagnostics landscape, including Abbott Laboratories, Siemens Healthineers AG, Beckman Coulter Inc., Becton dic*kinson and Company, Instrumentation Laboratory Company, Nova Biomedical Corporation, Qiagen NV, F Hoffmann La Roche Ltd, Biomeriux SA, Quidel Corporation, Orasure Technologies Inc., Johnson and Johnson, Thermo Fisher Scientific Inc., Sysmex Corporation, Sinocare Inc., Arkray Inc., Danaher Corporation, Chembio Diagnostics Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Fluxergy Inc., LumiraDx UK Ltd., Meridian Bioscience Inc., Nipro Europe Group Companies, AccuBioTech Co. Ltd., Atlas Genetics Ltd., Biomeme Inc., and Cepheid Inc.

A notable recent development occurred in July 2024, when Roche, the Switzerland-based pharmaceutical giant, acquired LumiraDx's point-of-care technology for an undisclosed sum. This strategic acquisition aims to strengthen Roche's foothold in diagnostic testing within primary care environments. LumiraDx, based in the US, specializes in innovative point-of-care diagnostic solutions.

View the full point of care diagnostics market report:
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Emerging Technological Trends Shaping the Point of Care Diagnostics Market
Innovation remains at the forefront of competition in the point of care diagnostics field, with major companies pushing to develop advanced technologies like rapid PCR systems. These systems offer quicker results compared to conventional PCR tests, enhancing diagnostic efficiency.

For example, in January 2023, Cipla, an India-based pharmaceutical company, unveiled its point-of-care testing device named Cippoint. This compact and user-friendly platform is designed to provide swift and accurate diagnostic results for a variety of health conditions. Its versatility makes it suitable for use in settings such as hospitals and clinics, empowering healthcare professionals to perform tests more effectively.

Detailed Segmentation of the Point of Care Diagnostics Market
The market report segments the point of care diagnostics industry into several key categories:

1) By Product:
- Glucose Monitoring Kits
- Infectious Diseases Testing Kits
- Pregnancy And Fertility Testing Kits
- Hematology Testing Kits
- Cardiometabolic Monitoring Kits
- Urinalysis Testing Kits
- Cholesterol Test Strips
- Other Products

2) By Mode of Prescription:
- Prescription-Based Devices
- Over-The-Counter (OTC) Devices

3) By End User:
- Professional Diagnostic Centers
- Research Laboratories
- Home Care
- Other End-Users

Further subcategories include:

- Glucose Monitoring Kits: Blood Glucose Meters, Test Strips
- Infectious Diseases Testing Kits: Rapid Antigen Tests, PCR Testing Kits, Serology Tests
- Pregnancy And Fertility Testing Kits: Home Pregnancy Tests, Ovulation Predictor Kits
- Hematology Testing Kits: Complete Blood Count (CBC) Test Kits, Coagulation Test Kits
- Cardiometabolic Monitoring Kits: Lipid Profile Test Kits, Blood Pressure Monitors
- Urinalysis Testing Kits: Dipstick Test Kits, Urine Culture Kits
- Cholesterol Test Strips: Home Cholesterol Testing Kits
- Other Products: Customizable Test Kits, Point Of Care Testing Platforms

This segmentation provides a comprehensive framework to understand the diverse product offerings, distribution methods, and user groups shaping the point of care diagnostics market today and into the future.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.